We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.6B
AUM Growth
+$570M
Cap. Flow
-$224M
Cap. Flow %
-1.27%
Top 10 Hldgs %
20.72%
Holding
1,372
New
93
Increased
502
Reduced
569
Closed
82

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$54.9M
2
ACN icon
Accenture
ACN
+$54.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$36.3M
4
IT icon
Gartner
IT
+$35.8M
5
HUM icon
Humana
HUM
+$32.6M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$61.7M
2
DHR icon
Danaher
DHR
+$38.4M
3
PGR icon
Progressive
PGR
+$36.4M
4
ADP icon
Automatic Data Processing
ADP
+$33.9M
5
PAYX icon
Paychex
PAYX
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Healthcare 12.8%
3 Financials 9.66%
4 Consumer Discretionary 8.95%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIT icon
901
Global X Lithium & Battery Tech ETF
LIT
$1.53B
$401K ﹤0.01%
6,313
MFC icon
902
Manulife Financial
MFC
$74B
$401K ﹤0.01%
21,832
+3,563
+20% +$67.8K
SLF icon
903
Sun Life Financial
SLF
$45.9B
$401K ﹤0.01%
8,580
-290
-3% -$14K
PLUS icon
904
ePlus
PLUS
$2.38B
$396K ﹤0.01%
8,066
-44
-0.5% -$2.23K
CWAN
905
DELISTED
Clearwater Analytics
CWAN
$393K ﹤0.01%
24,615
+10,155
+70% +$178K
AMPH icon
906
Amphastar Pharmaceuticals
AMPH
$899M
$393K ﹤0.01%
10,471
-29
-0.3% -$951
DVYE icon
907
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$393K ﹤0.01%
16,000
ENTG icon
908
Entegris
ENTG
$17.8B
$391K ﹤0.01%
4,771
-430
-8% -$34.8K
AGO icon
909
Assured Guaranty
AGO
$3.73B
$391K ﹤0.01%
+7,783
New +$452K
FUL icon
910
H.B. Fuller
FUL
$2.98B
$390K ﹤0.01%
5,697
+531
+10% +$37.1K
EIX icon
911
Edison International
EIX
$30.3B
$390K ﹤0.01%
5,523
-1,364
-20% -$92.1K
UAL icon
912
United Airlines
UAL
$40.1B
$389K ﹤0.01%
8,795
+208
+2% +$9.97K
CBOE icon
913
Cboe Global Markets
CBOE
$31B
$387K ﹤0.01%
2,885
+103
+4% +$12.9K
BRKL
914
DELISTED
Brookline Bancorp
BRKL
$386K ﹤0.01%
36,771
-16,239
-31% -$205K
AXNX
915
DELISTED
Axonics, Inc. Common Stock
AXNX
$386K ﹤0.01%
7,070
-2,580
-27% -$151K
XHB icon
916
State Street SPDR S&P Homebuilders ETF
XHB
$1.61B
$383K ﹤0.01%
5,656
-1,877
-25% -$125K
NDSN icon
917
Nordson
NDSN
$16.4B
$381K ﹤0.01%
1,715
-64
-4% -$14.6K
ORA icon
918
Ormat Technologies
ORA
$5.94B
$380K ﹤0.01%
4,488
+627
+16% +$55K
MP icon
919
MP Materials
MP
$7.42B
$380K ﹤0.01%
13,491
+3,047
+29% +$92.2K
RIO icon
920
Rio Tinto
RIO
$158B
$379K ﹤0.01%
5,522
+352
+7% +$25.5K
APA icon
921
APA Corp
APA
$12.8B
$379K ﹤0.01%
10,504
-1,603
-13% -$64.3K
MTSI icon
922
MACOM Technology Solutions
MTSI
$19B
$378K ﹤0.01%
5,343
-23
-0.4% -$1.55K
LEG icon
923
Leggett & Platt
LEG
$1.37B
$376K ﹤0.01%
11,799
PTC icon
924
PTC
PTC
$15.7B
$376K ﹤0.01%
2,930
+1
+0% +$127
SON icon
925
Sonoco
SON
$5.62B
$374K ﹤0.01%
6,123
+270
+5% +$16K

Similar funds

Glenmede Trust's Q1 2023 Portfolio in Review

As of Q1 2023, Glenmede Trust held 1,372 positions worth $17.6B, up 3.3% from $17B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Glenmede Trust's Q1 2023 filing shows 93 new, 502 increased, 569 reduced and 82 closed positions. Its largest new stake was Zoom: 177,014 shares worth $13.1M. The largest sale was Advanced Micro Devices, an estimated $61.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q1 2023 buy was Zoom: 177,014 shares worth $13.1M.
  • Glenmede Trust added most to Procter & Gamble in Q1 2023, an estimated $54.9M increase.
  • Glenmede Trust's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $61.7M.
  • Glenmede Trust fully exited Matador Resources in Q1 2023, selling an estimated $17.9M.
  • Glenmede Trust's ten largest holdings make up 21% of its $17.6B portfolio in Q1 2023.
  • Glenmede Trust opened 93 new positions and closed 82 in Q1 2023.
  • Glenmede Trust's portfolio value rose 3.3% quarter-over-quarter to $17.6B.

Based on Glenmede Trust's 13F filing for Q1 2023, filed 15 May 2023.